PYPD Projected Dividend Yield
Com No Par/PolyPid Ltd ( NASDAQ : PYPD )PolyPid is a clinical-stage biopharmaceutical company focused on developing targeted, locally administered and prolonged-release therapeutics using its proprietary Polymer-Lipid Encapsulation matrix (PLEX) technology. Co.'s product candidates are designed to address diseases with unmet medical needs by pairing its PLEX technology with drugs already approved by the U.S. Food and Drug Administration. Co.'s PLEX technology is designed to deliver drugs directly to precise sites in the body at predetermined release rates and over durations ranging from several days to several months. Co.'s primary product candidate, D-PLEX100, is for abdominal (soft) tissue. 20 YEAR PERFORMANCE RESULTS |
PYPD Dividend History Detail PYPD Dividend News PYPD Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |